Impact of Sitagliptin on Cardiovascular Exercise Performance in Type 2 Diabetes

NCT01951339 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

36

Enrollment

OTHER

Sponsor class

Conditions

Type 2 Diabetes
Cardiovascular Disease

Interventions

DRUG: Sitagliptin
DRUG: Glimepiride
DRUG: Placebo
DRUG: Placebo

Sponsor

University of Colorado, Denver

Collaborators

[object Object]